-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Initiates Coverage On Kairos Pharma with Buy Rating, Announces Price Target of $12

Benzinga·04/03/2025 10:51:33
Listen to the news
HC Wainwright & Co. analyst Joseph Pantginis initiates coverage on Kairos Pharma (AMEX:KAPA) with a Buy rating and announces Price Target of $12.